Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global DCT Market Portraiture
2.2. Global DCT Market, by Treatment, 2017 (US$ Mn)
2.3. Global DCT Market, by Geography, 2017 (US$ Mn)
Chapter 3. Dilated Cardiomyopathy Therapeutics (DCT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global DCT Market, by Key Players, 2017
Chapter 4. Global Dilated Cardiomyopathy Therapeutics (DCT) Market, by Treatment
4.1. Overview
4.2. Drug Class
4.2.1. Angiotensin II Receptor Blockers
4.2.2. Angiotensin-Converting Enzyme (ACE) Inhibitors
4.2.3. Beta Blockers
4.2.4. Anticoagulants
4.2.5. Digitalis
4.2.6. Diuretics
4.3. Implantable Device
4.3.1. Heart Pumps
4.3.2. Biventricular Pacemakers
4.3.3. Implantable Cardioverter-Defibrillators
4.4. Pipeline Analysis
4.4.1. Phase III Drugs
4.4.1.1. Enalapril Orodispersible Minitablet
4.4.1.2. ARRY-371797
4.4.1.3. ixCELL-DCM
4.4.2. Tabular Representation of Drug Pipeline in Phase II and I
Chapter 5. Global Dilated Cardiomyopathy Therapeutics (DCT) Market, by Geography
5.1. Overview
5.2. North America DCT Market Analysis, 2016 – 2026
5.2.1. North America DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
5.2.2. North America DCT Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe DCT Market Analysis, 2016 – 2026
5.3.1. Europe DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
5.3.2. Europe DCT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific DCT Market Analysis, 2016 – 2026
5.4.1. Asia Pacific DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific DCT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America DCT Market Analysis, 2016 – 2026
5.5.1. Latin America DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
5.5.2. Latin America DCT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East and Africa DCT Market Analysis, 2016 – 2026
5.6.1. MEA DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
5.6.2. MEA DCT Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Aastrom Biosciences
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Treatment Portfolio
6.1.4. News Coverage
6.2. Capricor Therapeutics
6.3. GlaxoSmithKline plc.
6.4. Johnson and Johnson
6.5. Kasiak Research Pvt. Ltd.
6.6. Merck & Co., Inc.
6.7. MyoKardia
6.8. Pfizer Inc.
6.9. t2cure GmbH.
6.10. Teva Pharmaceutical Industries
6.11. ZensunSci & tech.
List of Figures
FIG. 1 Dilated Cardiomyopathy Therapeutics (DCT) Market: Research Methodology
FIG. 2 DCT Market Segmentation
FIG. 3 Global DCT Market, by Treatment, 2017 (US$ Mn)
FIG. 4 Global DCT Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global DCT Market, by Key Players, 2017
FIG. 7 Global Angiotensin II Receptor Blockers Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 8 Global ACE Inhibitors Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 9 Global Beta Blockers Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 10 Global Anticoagulants Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 11 Global Digitalis Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 12 Global Diuretics Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 13 Global Heart Pumps Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Biventricular Pacemakers Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 15 Global Implantable Cardioverter-Defibrillators Market for Dilated Cardiomyopathy Therapeutics, 2016 – 2026 (US$ Mn)
FIG. 16 U.S. DCT Market, 2016 – 2026 (US$ Mn)
FIG. 17 Canada DCT Market, 2016 – 2026 (US$ Mn)
FIG. 18 U.K. DCT Market, 2016 – 2026 (US$ Mn)
FIG. 19 Germany DCT Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Europe DCT Market, 2016 – 2026 (US$ Mn)
FIG. 21 China DCT Market, 2016 – 2026 (US$ Mn)
FIG. 22 Japan DCT Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Asia Pacific DCT Market, 2016 – 2026 (US$ Mn)
FIG. 24 Brazil DCT Market, 2016 – 2026 (US$ Mn)
FIG. 25 Mexico DCT Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of Latin America DCT Market, 2016 – 2026 (US$ Mn)
FIG. 27 GCC DCT Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of MEA DCT Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global DCT Market (DCT) Market Portraiture
TABLE 2 Global DCT Market Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 3 Global Drug Class Market for DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 4 Global Implantable Device Market for DCT Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 5 Global DCT Market Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America DCT Market Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 7 North America DCT Market Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe DCT Market Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 9 Europe DCT Market Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific DCT Market Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific DCT Market Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America DCT Market Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America DCT Market Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa DCT Market Market, by Treatment, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa DCT Market Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Aastrom Biosciences: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 17 Capricor Therapeutics: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 18 GlaxoSmithkline Plc.: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 19 Johnson and Johnson: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 20 Kasiak Research Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 21 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 22 Myokardia: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 23 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 24 T2cure GmbH: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 25 Teva Pharmaceuticals Industries: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)
TABLE 26 ZensunSci & tech.: Company Snapshot (Business Description; Financial Information; Treatment Portfolio; Key Developments)